$ABM

Top Wall Street Forecasters Revamp ABM Industries Price Target Ahead Of Q2 Earnings

ABM Industries (NYSE: ABM) is set to report fiscal Q2 earnings before the open on Friday, June 5. Analysts expect EPS of 88 cents (up 2.3% y/y) on revenue of $2.21 billion (up 5.2% y/y). The article notes ABM shares rose 1.76% to $39.88 on Thursday and that the company received a 4-Star Employer designation in May 2026.

Original reporting
Published Jun 5, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 10:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top Wall Street Forecasters Revamp ABM Industries Price Target Ahead Of Q2 Earnings — source image
Decision brief

The 30-second read

$ABMNeutralMed
01

Why it matters

The immediate tradable catalyst is the upcoming earnings release versus the provided consensus EPS and revenue figures; employer-awards content is unlikely to move price materially.

02

Market read

Near-term trading focus is earnings volatility around consensus expectations; employer-awards recognition is secondary.

03

What to watch

The article omits any specific analyst rating changes or guidance details; traders should focus on management commentary, backlog/contract wins, and margin trajectory on the print.

Relevance 8/10Novelty 4/10Timing: Ahead of pre-market Q2 earnings on June 5

Background

ABM Industries reports fiscal Q2 earnings before the open on Friday, June 5; the article frames expectations and notes a recent employer-awards recognition.

Company-level read

Ticker impact

$ABMNeutralMedium confidence
Context

Article centers on ABM’s pre-market Q2 earnings on June 5 and the Street’s EPS/revenue expectations ahead of the print.

Expected impact

Moderate two-sided move risk into the open; direction likely hinges on whether results beat/guide versus the stated consensus.

Evidence & confidence

The piece provides the earnings timing plus consensus EPS ($0.88) and revenue ($2.21B), but no new guidance or actual results yet.

Market effects

ABM is a facilities/services bellwether; results can influence sentiment for similarly exposed commercial services names.

Limited—company-specific earnings with no stated regional macro catalyst.

Low—no international deal/regulatory developments mentioned.

Counterpoint

Even with consensus growth, ABM could trade on margin/FCF or guidance quality rather than headline EPS/revenue.

Key entities

  • ABM Industries Inc

    Subject of the article; scheduled to report fiscal Q2 earnings pre-market June 5.

Related articles

$ABMMedAI 8/10

ABM Reaffirms FY26 Outlook

ABM reaffirmed its FY2026 outlook, expecting organic revenue growth toward the top end of 3%–4% and total revenue growth toward 4%–5%. Segment operating margin is projected near the low end of 7.8%–8.0%, with adjusted EPS of $3.85–$4.15. In Q2, net income was $43.1M ($0.73/share) on $2.3B revenue (+8.4% YoY). ABM declared a $0.29 dividend.

$ABMMedAI 8/10

Aben Gold Announces Up to $1.5 million Non-Brokered Flow-Through Private Placement

Aben Gold Corp. (TSX-V: ABM) announced a non-brokered flow-through private placement to raise up to $1.5 million by issuing up to 7.5 million FT units at $0.20 each. Each unit includes a flow-through share and half a warrant exercisable at $0.30 for 24 months. Proceeds fund exploration and drilling on its Justin gold-tungsten property in Yukon; TSX Venture approval is required.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.